Impact of Virologic Breakthrough and HBIG Regimen on Hepatitis B Recurrence after Liver Transplantation

The availability of HBIG and several oral antiviral therapies have reduced but not eliminated HBV recurrence. We aimed to determine the rate of HBV recurrence after orthotopic liver transplantation (OLT) in relation to virologic breakthrough pre-OLT and HBIG regimens post-OLT. Data from the NIH HBV-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Degertekin, Bulent, Han, Steven-Huy B., Keeffe, Emmet B., Schiff, Eugene R., Luketic, Velimir A., Brown, Robert S., Emre, Sukru, Soldevila-Pico, Consuelo, Reddy, K. Rajender, Ishitani, Michael B., Tran, Tram T., Pruett, Timothy L., Lok, Anna S. F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2910807/
https://ncbi.nlm.nih.gov/pubmed/20346062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-6143.2010.03046.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados